Hedge Fund - Rhenman & Partners Asset Management
Boston Scientific Corp (BSX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $30,264,000 | 3.48% | 300,000 | $100.70 |
| 2 | 2024 - Q4 (2024-12-31) | $39,658,080 | 4.07% | 444,000 | $88.03 |
| 3 | 2024 - Q3 (2024-09-30) | $49,442,000 | 4.01% | 590,000 | $78.83 |
| 4 | 2024 - Q2 (2024-06-30) | $45,820,950 | 4.39% | 595,000 | $73.20 |
| 5 | 2024 - Q1 (2024-03-31) | $39,861,180 | 3.77% | 582,000 | $64.30 |
| 6 | 2023 - Q4 (2023-12-31) | $43,357,500 | 4.33% | 750,000 | $53.38 |
| 7 | 2023 - Q3 (2023-09-30) | $36,960,000 | 3.98% | 700,000 | $52.45 |
| 8 | 2023 - Q2 (2023-06-30) | $31,372,200 | 3.3% | 580,000 | $52.23 |
| 9 | 2023 - Q1 (2023-03-31) | $29,760,000 | 3.26% | 600,000 | $47.13 |
| 10 | 2022 - Q4 (2022-12-31) | $27,067,950 | 2.82% | 585,000 | $43.30 |
| 11 | 2022 - Q3 (2022-09-30) | $29,961,000 | 3.13% | 695,000 | $40.12 |
| 12 | 2022 - Q2 (2022-06-30) | $27,021,000 | 3.07% | 725,000 | $40.71 |
| 13 | 2022 - Q1 (2022-03-31) | $22,588,000 | 2.22% | 510,000 | $43.34 |
| 14 | 2021 - Q4 (2021-12-31) | $39,121,000 | 2.6% | 910,000 | $42.02 |
| 15 | 2021 - Q3 (2021-09-30) | $24,732,000 | 1.73% | 570,000 | $44.24 |
| 16 | 2021 - Q2 (2021-06-30) | $22,235,000 | 1.5% | 520,000 | $42.07 |
| 17 | 2021 - Q1 (2021-03-31) | $25,896,000 | 1.8% | 670,000 | $37.85 |
| 18 | 2020 - Q4 (2020-12-31) | $19,054,000 | 1.55% | 530,000 | $36.04 |
| 19 | 2020 - Q3 (2020-09-30) | $17,195,000 | 1.52% | 450,000 | $38.53 |
| 20 | 2020 - Q2 (2020-06-30) | $14,395,000 | 1.55% | 410,000 | $36.01 |
| 21 | 2020 - Q1 (2020-03-31) | $18,436,000 | 2.58% | 565,000 | $39.07 |
| 22 | 2019 - Q4 (2019-12-31) | $20,424,000 | 2.23% | 451,668 | $41.84 |
| 23 | 2019 - Q3 (2019-09-30) | $15,055,000 | 1.88% | 370,000 | $42.37 |
| 24 | 2019 - Q2 (2019-06-30) | $16,672,000 | 1.83% | 387,908 | $38.46 |
| 25 | 2018 - Q4 (2018-12-31) | $13,355,000 | 1.52% | 377,908 | $36.27 |
| 26 | 2018 - Q3 (2018-09-30) | $13,012,000 | 1.3% | 337,968 | $34.93 |
| 27 | 2018 - Q2 (2018-06-30) | $11,379,000 | 1.16% | 347,968 | $30.16 |
| 28 | 2018 - Q1 (2018-03-31) | $9,506,000 | 1.17% | 347,968 | $27.18 |
| 29 | 2017 - Q4 (2017-12-31) | $8,626,000 | 1.16% | 347,968 | $27.58 |
| 30 | 2017 - Q3 (2017-09-30) | $8,181,000 | 1.04% | 280,468 | $27.62 |
| 31 | 2016 - Q1 (2016-03-31) | $0 | 0% | 0 | $17.57 |
| 32 | 2015 - Q4 (2015-12-31) | $5,053,000 | 0.76% | 274,000 | $17.92 |
The displayed share prices are average quarterly stock market prices.